Heart Beat: January 2011

Cardiologists prescribe cholesterol-lowering statins to help patients reduce their risk of heart attack or stroke by lowering their LDL cholesterol levels. Physicians now can provide statins to patients without high cholesterol but who have elevated levels of inflammation or C-reactive protein (CRP), which has been identified as a major risk factor for cardiovascular disease. The U.S. Food and Drug Administration approved the use of rosuvastatin (Crestor) based on the results of an international study, JUPITER. It found that healthy people with normal or low cholesterol but high CRP who took rosuvastatin cut their risk of death from heart attack or stroke by 44 percent compared with placebo-treated patients.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access